✦ LIBER ✦

25 A retrospective analysis of patients with advanced EGFR mutated lung cancer treated with either first line erlotinib or gefitinib

✍ Scribed by Thillai, K.; Soultati, A.; Montes, A.; Karapanagiotou, E.; Spicer, J.; Lal, R.

Book ID: 122705479
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 49 KB
Volume: 83
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(14)70026-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

26 Audit of gefitinib for the first-line

26 Audit of gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in patients with EGFR mutation

✍ Douglas, R.; Campbell, L.; McAleese, J.; Scullin, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGF

PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL

✍ O Arrieta; P Anaya; RJ López; AC Polanco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Gefitinib as First-line Treatment in Eld

Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study

✍ Kazuhiro Asami; Tomonobu Koizumi; Kazuya Hirai; Shingo Ameshima; Akihiro Tsukada 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 308 KB

Erlotinib alone or with bevacizumab as f

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

✍ Seto, Takashi; Kato, Terufumi; Nishio, Makoto; Goto, Koichi; Atagi, Shinji; Hoso 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 398 KB

9123 POSTER Final Results of a Phase II

9123 POSTER Final Results of a Phase II Study of Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Non-small Cell Lung Cancer – Gefitinib for Elderly Patients With Lung Adenocarcinoma

✍ Asami, K.; Koizumi, T.; Hirai, K.; Ameshima, S.; Tsukadaira, A.; Morozumi, N.; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB